Bitcoin price today: dips below $112k, near 6-wk low despite Fed cut bets
Safety Shot, Inc. (NASDAQ:SHOT) reported Monday a significant increase in equity following the appreciation of its holdings in SRM Entertainment, Inc. The company disclosed that as of June 30, 2025, it held 2,347,142 shares of SRM Entertainment’s common stock, which are classified as marketable securities.
According to the company’s statement in a press release, the value of these shares rose from $0.41 per share as of March 31, 2025, to $7.75 per share as of June 30, 2025. This increase brought the aggregate value of Safety Shot’s SRM Entertainment shares to approximately $18.2 million, up from about $1.0 million three months earlier. The company noted that this resulted in an increase in equity of approximately $17 million.
Safety Shot originally acquired 4,500,000 shares of SRM Entertainment common stock in connection with the sale of its former wholly owned subsidiary, SRM Entertainment, Ltd., and SRM Entertainment’s initial public offering completed on August 14, 2023.
As of the filing date of the current report, Safety Shot stated that its stockholder’s equity is above $5 million.
Safety Shot’s common stock and warrants are listed on The Nasdaq Stock Market LLC under the symbols (NASDAQ:SHOT) and NASDAQ:SHOTW, respectively.
All information is based on a statement from the company’s press release filed with the Securities and Exchange Commission.
In other recent news, Safety Shot, Inc. has successfully completed its acquisition of Yerbae Brands Corp. through a court-approved plan of arrangement. This transaction resulted in Yerbae shareholders receiving 0.2918 Safety Shot shares for each Yerbae share held, leading to the issuance of approximately 19,881,948 Safety Shot shares to former Yerbae shareholders. Following this acquisition, Safety Shot shareholders now own about 81.64% of the combined company, while former Yerbae shareholders hold around 18.36%. Additionally, Safety Shot shareholders approved an expansion of the company’s 2024 Equity Incentive Plan, increasing the number of shares reserved for issuance by an additional 22 million. This strategic move aims to enhance the company’s ability to incentivize its employees through stock-based compensation. Furthermore, Safety Shot announced plans to enter the cognitive enhancement and sleep aid markets, leveraging its scientific expertise to develop nootropics and sleep aids. The company is focusing on creating products that support mental functions and improve sleep quality, aligning with its mission to promote well-being through science-backed solutions. Lastly, Maxim Group LLC served as the exclusive financial advisor to Safety Shot for the merger, highlighting the company’s strategic initiatives to drive future growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.